Medical Journals

The Hemoglobin Receptor Protein of Porphyromonas Gingivalis Inhibits Receptor Activator Nf-kappab Ligand-induced Osteoclastogenesis from Bone Marrow Macrophages.

Authors:
  • Fujimura Yuji
  • Hotokezaka Hitoshi
  • Ohara Naoya
  • Naito Mariko
  • Sakai Eiko
  • Yoshimura Mamiko
  • Narita Yuka
  • Kitaura Hideki
  • Yoshida Noriaki
  • Nakayama Koji

From: Division of Microbiology and Oral Infection, Department of Developmental and Reconstructive Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.

Infection and immunity

  • Publish Date: May 2006
  • ISSN: 0019-9567
  • Volume: 74
  • Issue: 5
  • Pages: 2544-51
  • Medium: Print
  • Language: English
  • Citation (JAMA): Fujimura Yuji, Hotokezaka Hitoshi, Ohara Naoya, et al. The Hemoglobin Receptor Protein of Porphyromonas Gingivalis Inhibits Receptor Activator Nf-kappab Ligand-induced Osteoclastogenesis from Bone Marrow Macrophages.. Infect. Immun. May 2006;74:2544-51

Abstract

Extracellular proteinaceous factors of Porphyromonas gingivalis, a periodontal pathogen, that influence receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced osteoclastogenesis from bone marrow macrophages were investigated. The culture supernatant of P. gingivalis had the ability to inhibit RANKL-induced in vitro osteoclastogenesis. A major protein of the culture supernatant, hemoglobin receptor protein (HbR), suppressed RANKL-induced osteoclastogenesis in a dose-dependent fashion. HbR markedly inhibited RANKL-induced osteoclastogenesis when present in the culture for the first 24 h after addition of RANKL, whereas no significant inhibition was observed when HbR was added after 24 h or later, implying that HbR might interfere with only the initial stage of RANKL-mediated differentiation. HbR tightly bound to bone marrow macrophages and had the ability to induce phosphorylation of ERK, p38, NF-kappaB, and Akt. RANKL-induced phosphorylation of ERK, p38, and NF-kappaB was not suppressed by HbR, but that of Akt was markedly suppressed. HbR inhibited RANKL-mediated induction of c-Fos and NFATc1. HbR could induce beta interferon (IFN-beta) from bone marrow macrophages, but the induction level of IFN-beta might not be sufficient to suppress RANKL-mediated osteoclastogenesis, implying presence of an IFN-beta-independent pathway in HbR-mediated inhibition of osteoclastogenesis. Since rapid and extensive destruction of the alveolar bone causes tooth loss, resulting in loss of the gingival crevice that is an anatomical niche for periodontal pathogens such as P. gingivalis, the suppressive effect of HbR on osteoclastogenesis may help the microorganism exist long in the niche.

Mesh Headings (Keywords): Animals, Apoptosis, Bacterial Proteins, Bone Marrow Cells, Carrier Proteins, Cell Differentiation, Interferon-beta, Macrophages, Male, Membrane Glycoproteins, Mice, Osteoclasts, Osteogenesis, Porphyromonas gingivalis, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B, Receptors, Cell Surface, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 16622189


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.